These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19007778)

  • 1. Implications of elevated serum alanine aminotransferase levels: think outside the liver.
    Ioannou GN
    Gastroenterology; 2008 Dec; 135(6):1851-4. PubMed ID: 19007778
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
    Ruhl CE; Everhart JE
    Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
    Kim CH; Park JY; Lee KU; Kim JH; Kim HK
    Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.
    Yilmaz Y; Ulukaya E; Dolar E
    Hepatology; 2009 Feb; 49(2):697; author reply 697. PubMed ID: 19035337
    [No Abstract]   [Full Text] [Related]  

  • 5. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
    Ahmed MH
    Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
    [No Abstract]   [Full Text] [Related]  

  • 6. Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease.
    Hsu CS; Chen DS; Kao JH
    Hepatology; 2009 Sep; 50(3):989; author reply 989-90. PubMed ID: 19714722
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alanine aminotransferase activity and mortality in older people.
    Hovinen SM; Pitkala KH; Tilvis RS; Strandberg TE
    J Am Geriatr Soc; 2010 Jul; 58(7):1399-401. PubMed ID: 20649695
    [No Abstract]   [Full Text] [Related]  

  • 9. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies.
    Clark JM; Diehl AM
    Gastroenterology; 2003 Jan; 124(1):248-50. PubMed ID: 12512048
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship.
    Baou K; Vlachopoulos C; Manesis E; Archimandritis A; Stefanadis C
    Hellenic J Cardiol; 2007; 48(1):37-41. PubMed ID: 17388108
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clues from the carotids: an appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1315-7. PubMed ID: 19702897
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver enzymes, fatty liver and type 2 diabetes.
    Neely D
    Ann Clin Biochem; 2005 May; 42(Pt 3):167-9. PubMed ID: 15949150
    [No Abstract]   [Full Text] [Related]  

  • 15. Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments.
    Yilmaz Y; Kurt R; Kalayci C
    Biomark Med; 2010 Oct; 4(5):743-5. PubMed ID: 20945987
    [No Abstract]   [Full Text] [Related]  

  • 16. High prevalence of non-virus/non-alcohol-related alanine-aminotransferase increase in blood donors.
    Morisco F; Di Lonardo A; Stroffolini T; Leone D; Caporaso N
    Haematologica; 2001 Oct; 86(10):1116. PubMed ID: 11602426
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum alanine aminotransferase level alone may not accurately represent necro-inflammation in patients with acute hepatitis.
    Seo YS; Um SH; Jung ES; Yim HJ; Kim CD; Ryu HS
    Hepatology; 2009 Mar; 49(3):1053-4; author reply 1054-5. PubMed ID: 19241482
    [No Abstract]   [Full Text] [Related]  

  • 18. The trouble with biopsies..
    Baumann U; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):122. PubMed ID: 16819390
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevation of collagenase activity in fatty liver.
    Watanabe A; Kobayashi M
    Hiroshima J Med Sci; 1987 Dec; 36(4):417-9. PubMed ID: 2834308
    [No Abstract]   [Full Text] [Related]  

  • 20. Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: a missing link?
    Wang CC; Kao JH
    Am J Gastroenterol; 2010 Jan; 105(1):224; author reply 224-5. PubMed ID: 20054315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.